Calnex Solutions PLC (LSE: CLX) has spent much of 2026 quietly rebuilding investor confidence. The Scottish network testing specialist reported a 19% rise in revenue to £21.9 million for the year to 31 March 2026, alongside a 73% jump in profit before tax to around £1.2 million.

The AIM-listed small cap, valued at roughly £54 million, supplies the test and measurement instruments that telecom operators, equipment makers and cloud companies use to validate network timing and performance. It is a niche business, but one that sits at the centre of several powerful technology trends.

Those trends include the continuing global 5G rollout, the race to build AI-ready data centres and rising government and defence spending on secure communications — all markets where precise network synchronisation and realistic network testing are becoming harder to avoid.

After a punishing two-year downturn in telecom equipment spending, the question for followers of UK telecom stocks is whether Calnex's recovery has further to run — and whether its diversification beyond a telecoms heritage can smooth out the cycle next time around.

Calnex Solutions at a glance: what this UK telecom stock actually does

Founded in 2006 and headquartered in Linlithgow, Scotland, Calnex Solutions designs and manufactures test and measurement instruments for network synchronisation and network emulation. Its equipment allows customers to prove that data flowing across telecoms networks, data centres and cloud platforms arrives accurately, on time and in the right order. The company was founded by chief executive Tommy Cook, a veteran of the telecoms test industry, and has built its reputation supplying many of the world's largest network operators and equipment vendors.

The flagship Paragon range tests timing and synchronisation performance, an area that has become critical as 5G networks depend on ultra-precise coordination between base stations. The Paragon Neo-S product supports synchronisation testing at speeds of 800 gigabits per second, while the Sentry line has been performing strongly in the data centre market. A network emulation product known as SNE is progressing through development and is expected to begin generating revenue in the latter part of 2027.

Calnex sells to telecom network operators, network equipment manufacturers, hyperscale cloud providers and, increasingly, government and defence customers. It joined AIM in October 2020, making it one of the few London-listed telecommunications stocks offering pure-play exposure to network test and measurement — a field otherwise dominated by much larger US-listed groups.

The operating model combines hardware instruments with software and sustained R&D investment. Because its instruments are used at the design, rollout and monitoring stages of network infrastructure, demand tends to follow customers' investment cycles — a strength when capital spending is rising and a vulnerability when budgets tighten.

In November 2025 the company agreed a go-to-market partnership with VIAVI Solutions, a major US test and measurement player, designed to extend Calnex's commercial reach across the telecoms, data centre and defence sectors.

Market context: 5G testing demand meets the AI infrastructure boom

The backdrop matters for a company of this size. Worldwide telecom capital expenditure contracted in 2023 — the first annual decline since 2017, according to industry analysts — as operators scaled back 5G and fixed broadband spending and worked through excess inventory. Operators in Europe and North America paused or stretched rollout timetables, and equipment vendors cut forecasts. Test and measurement suppliers, whose fortunes track equipment demand, felt the squeeze, and Calnex's revenue and share price both retreated from their post-IPO highs.

Signs of stabilisation began to emerge from late 2024, helped by an extraordinary surge in spending from hyperscale cloud companies building AI infrastructure. That shift plays directly into Calnex's diversification strategy: the company reported growing traction in cloud computing and data centre markets in FY26, including a sizeable repeat order from a major hyperscaler received shortly after the year end.

On the telecoms side, the 5G story is evolving rather than ending. Attention is moving towards standalone 5G, Open RAN architectures and, increasingly, AI-enabled radio networks. Calnex showcased three live demonstrations at MWC Barcelona 2026 focused on simplifying conformance testing across Open RAN and AI RAN ecosystems — a signal of where it sees future testing demand emerging.

In April 2026 the company also announced that it had achieved PFC-transparent 400G network emulation for validating lossless Ethernet in AI clusters, positioning its products in front of the data centre operators wrestling with the networking demands of large-scale AI training.

Analysts following the sector have noted that the inventory correction that dogged network equipment suppliers appears largely complete, with spending increasingly driven by cloud traffic growth and new AI workloads rather than handset-led 5G coverage builds. For testing specialists, that changes the shape of demand as much as the size of it.

Why investors may be watching Calnex Solutions

The most obvious reason is the return to growth. FY26 revenue of £21.9 million was up 19% year on year, net income more than doubled to around £0.7 million, and the company lifted its dividend — a statement of confidence that is relatively unusual among AIM-listed technology small caps.

The second is diversification. Calnex has deliberately broadened beyond its telecoms heritage into cloud computing, data centres, government and defence, including expanding opportunities linked to US federal contracts. If sustained, that mix could reduce the company's dependence on the notoriously cyclical telecom equipment demand cycle.

Third is the product pipeline. The SNE network emulator is expected to start contributing revenue in late 2027, and development is under way on a next-generation 1.6 terabit-per-second synchronisation testing product targeted for launch in the 2028 financial year, which the company says is already attracting customer interest.

Finally, there is the balance sheet. Cash stood at £9.3 million at 31 March 2026, with around £3 million of further customer receipts expected early in FY27 — meaningful headroom for a company of this scale. First-half FY26 revenue rose 9.4% to £8.05 million with a narrowed loss, before a stronger second half carried the group to its full-year outcome, a familiar pattern of second-half weighting. The shares have traded between 40.5p and 70p over the past year, suggesting sentiment has begun to recover, though they remain well below their earlier peaks.

Key factors to monitor

For those following this 5G stock, several indicators may help frame the story over the coming year:

• Order momentum from hyperscale data centre customers, including whether the recent repeat order from a major hyperscaler becomes a recurring pattern

• The pace of telecom operator spending on standalone 5G, Open RAN and network synchronisation upgrades

• Execution on new products — particularly the SNE network emulator and the 1.6Tb/s synchronisation tester targeted for FY28

• Early evidence that the VIAVI Solutions partnership is widening Calnex's commercial reach

• Gross margins and the balance between R&D investment and profitability during FY27

• Progress in government, defence and US federal opportunities

• Trading liquidity in the shares, which can be thin for an AIM company of this size

Risks to consider

Small-cap volatility is the starting point. With a market value of roughly £54 million, Calnex shares can move sharply on modest news flow, and the limited free float typical of AIM stocks means investors may find it difficult to buy or sell in size without affecting the price.

Customer concentration adds to that. Like many niche test and measurement businesses, Calnex relies on a relatively small pool of large customers, and individual orders can be significant relative to group revenue. The timing of a single hyperscaler or operator order can therefore swing results between reporting periods.

The telecom equipment demand cycle remains a structural risk. The 2023–24 downturn demonstrated how quickly operator capex can retrench, and a renewed slowdown — or a pause in AI-related data centre investment — could weigh on testing demand across the industry.

Competition is another consideration. Calnex competes in specialist niches against far larger rivals, including US test and measurement groups with deeper R&D budgets. Absolute profitability also remains modest, with FY26 net income of around £0.7 million, leaving limited room for missteps. Currency movements on international sales can further affect reported results.

Finally, technology risk should not be ignored. Test and measurement products must keep pace with each new generation of network speeds — from 400G to 800G and onwards towards 1.6 terabits — and any delay in product transitions could see customers defer purchases or look elsewhere.

Outlook

Calnex has described FY27 as a year of targeted investment in key products and customer relationships, with accelerated growth anticipated in FY28 as new initiatives — including the SNE emulator and the 1.6Tb/s tester — are commercialised. If that roadmap is delivered, the company could emerge with a broader, less cyclical revenue base than it had entering the last downturn.

Much depends on factors outside its control. Telecom operator budgets, hyperscaler capex plans and the wider appetite for AIM-listed small caps will all shape how the story unfolds, and continued growth in AI data centre networking may provide a supportive backdrop without automatically translating into orders. What can be said is that Calnex enters FY27 with net cash, a growing product pipeline and exposure to some of the strongest spending themes in global technology — a combination that may keep this small-cap telecom stock on watchlists even if progress proves uneven.

Conclusion

Calnex Solutions is a reminder that the UK market still hosts genuinely specialist technology businesses at small-cap scale. Its niche is technically demanding, its customer list is blue-chip, and its addressable markets are expanding beyond telecoms into data centres and defence. The FY26 results showed a company moving back in the right direction: revenue up 19%, profit sharply higher and cash comfortable.

Whether 5G testing demand, AI data centre spending and defence diversification can compound from here remains to be seen. For now, CLX offers a focused — if higher-risk — way to follow the infrastructure testing theme among LSE telecom shares, with the usual caveats about liquidity, customer concentration and cyclicality firmly attached.

Frequently asked questions about Calnex Solutions (CLX)